Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis

Fig. 2

Anti-CXCR3 (left) and anti-CXCR4 (right) antibody levels in diffuse cutaneous systemic sclerosis (dSSc), in patients with limited cutaneous systemic sclerosis (lSSc), with overlap syndromes (Overlap), with undifferentiated connective tissue disease (UCTD), and in healthy controls. P values with significant differences are shown

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us